Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2170-2175

  Bastian, Boris C ^a,b   LeBoit, Philip E ^a   Hamm, Henning ^b   Bröcker, Eva Bettina ^b   Pinkel, Dan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME 8; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME LOSS; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MELANOMA; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; SKIN TUMOR;

AGE FACTORS; CHROMOSOME ABERRATIONS; HUMANS; MELANOMA; NUCLEIC ACID HYBRIDIZATION; SKIN NEOPLASMS;

EID: 0032523833     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rigel, D. S., Friedman, R. J., and Kopf, A. W. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J. Am. Acad. Dermatol., 34: 839-847, 1996.
2. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J. F., Anderson, D. E., Bergman, W., Frants, R., Goldgar, D. E., Green, A., MacLennan, R., Martin, N. G., Meyer, L. J., Youl, P., Zone, J. J., Skolnick, M. H., and Cannon-Albright, L. A. Analysis of the p16 gene CDKN2 as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet., 8: 23-26, 1994.
3. INK4a binding domain of CDK4 in familial melanoma. Nat. Genet., 12: 97-99, 1996.
4. Mertens, F., Johansson, B., Hoglund, M., and Mitelman, F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res., 57: 2765-2780, 1997.
5. Trent, J. M. Cytogenetics of human malignant melanoma. Cancer Metastasis Rev., 10: 103-113, 1991.
6. Cowan, J. M., Halaban, R., and Francke, U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J. Natl. Cancer Inst., 80: 1159-1164, 1988.
7. Balaban, G., Herlyn, M., Guerry, D. T., Bartolo, R., Koprowski, H., Clark, W. H., and Nowell, P. C. Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet. Cytogenet., 11: 429-439, 1984.
8. Sozzi, G., Miozzo, M., Calderone, C., Fossati, G., Pierotti, M. A., Cascinelli, N., and Della Porta, G. Chromosome abnormalities and fragile sites in human melanoma. Cancer Genet. Cytogenet., 44: 61-67, 1990.
9. Balaban, G. B., Herlyn, M., Clark, W. H., Jr., and Nowell, P. C. Karyotypic evolution in human malignant melanoma. Cancer Genet. Gytogenet., 19: 113-122, 1986.
10. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
11. Breslow, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172: 902-909, 1970.
12. Isola, J., DeVries, S., Chu, L., Ghazvini, S., and Waldman, F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am. J. Pathol., 145: 1301-1308, 1994.
13. Kallioniemi, A., Kallioniemi, O. P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA, 91: 2156-2160, 1994.
14. Richter, J., Jiang, F., Gorog, J. P., Sartorius, G., Egenter, C., Gasser, T. C., Moch, H., Mihatsch, M. J., and Sauter, G. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res., 57: 2860-2864, 1997.
15. Fountain, J. W., Bale, S. J., Housman, D. E., and Dracopoli, N. C. Genetics of melanoma. Cancer Surv., 9: 645-671, 1990.
16. Houldsworth, J., and Chaganti, R. S. Comparative genomic hybridization: an overview. Am. J. Pathol., 145: 1253-1260, 1994.
17. Thompson, F. H., Emerson, J., Olson, S., Weinstein, R., Leavitt, S. A., Leong, S. P., Emerson, S., Trent, J. M., Nelson, M. A., Salmon, S. E., and Taetle, R. Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of neardiploid and simple karyotypes. Cancer Genet. Cytogenet., 83: 93-104, 1995.
18. Healy, E., Rehman, I., Angus, B., and Rees, J. L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer, 12: 152-156, 1995.
19. Walker, G. J., Palmer, J. M., Walters, M. K., and Hayward, N. K. A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes Cancer, 12: 134-141, 1995.
20. Parmiter, A. H., and Nowell, P. C. The Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Treat. Res., 43: 47-61, 1988.
21. Isshiki, K., Elder, D. E., Guerry, D., and Linnenbach, A. J. Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer, 8: 178-184, 1993.
22. Herbst, R. A., Weiss, J., Ehnis, A., Cavenee, W. K., and Arden, K. C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res., 54: 3111-3114, 1994.
23. Su, Y. A., Ray, M. E., Lin, T., Seidel, N. E., Bodine, D. M., Meltzer, P. S., and Trent, J. M. Reversion of monochromosome-mediated suppression of tumorigenicity in malignant melanoma by retroviral transduction. Cancer Res., 56: 3186-3191, 1996.
24. Ray, M. E., Su, S. Y. A., Meltzer, P. S., and Trent, J. M. Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma. Oncogene, 12: 2527-2533, 1996.
25. Koprowski, H., Herlyn, M., Balaban, G., Parmiter, A., Ross, A., and Nowell, P. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somat. Cell Mol. Genet., 11: 297-302, 1985.
26. Wiltshire, R. N., Duray, P., Bittner, M. L., Visakorpi, T., Meltzer, P. S., Tuthill, R. J., Liotta, L. A., and Trent, J. M. Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization. Cancer Res., 55: 3954-3957, 1995.
27. Grover, R., Ross, D. A., Richman, P. I., Robinson, B., and Wilson, G. D. C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity. Eur. J. Surg. Oncol., 22: 342-346, 1996.
28. Barks, J. H., Thompson, F. H., Taetle, R., Yang, J. M., Stone, J. F., Wymer, J. A., Khavari, R., Guan, X. Y., Trent, J. M., Pinkel, D., and Nelson, M. A. Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma. Genes Chromosomes Cancer, 19: 278-285, 1997.
29. Morse, H. G., Gonzalez, R., Moore, G. E., and Robinson, W. A. Preferential chromosome 11q and/or 17q aberrations in short-term cultures of metastatic melanoma in resections from human brain. Cancer Genet. Cytogenet., 64: 118-126, 1992.
30. Bröcker, E. B., Magiera, H., and Herlyn, M. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. J. Invest. Dermatol., 96: 662-665, 1991.
31. Korn, W. M., Oide Weghuis, D. E., Suijkerbuijk, R. F., Schmidt, U., Otto, T., du Manoir, S., Geurts van Kessel, A., Harstrick, A., Seeber, S., and Becher, R. Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridization. Genes Chromosomes Cancer, 17: 78-87, 1996.
32. Schröck, E., Thiel, G., Lozanova, T., du Manoir, S., Meffert, M. C., Jauch, A., Speicher, M. R., Nurnberg, P., Vogel, S., Jänisch, W., Donis-Keller, H., Ried, T., Witkowski, R., and Cremer, T. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol., 144: 1203-1218, 1994.
33. Richmond, A., Balentien, E., Thomas, H. G., Flaggs, G., Barton, D. E., Spiess, J., Bordoni, R., Francke, U., and Derynck, R. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to β-thromboglobulin. EMBO J., 7: 2025-2033, 1988.
34. Gronwald, R. G., Adler, D. A., Kelly, J. D., Disteche, C. M., and Bowen-Pope, D. F. The human PDGF receptor α-subunit gene maps to chromosome 4 in close proximity to c-kit. Hum. Genet., 85: 383-385, 1990.
35. Adelaide, J., Mattei, M. G., Maries, I., Raybaud, F., Planche, J., De Lapeyriere, O., and Birnbaum, D. Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma. Oncogene, 2: 413-416, 1988.
36. Marlhens, F., Achkar, W. A., Aurias, A., Couturier, J., Dutrillaux, A. M., Gerbault-Sereau, M., Hoffschir, F., Lamoliatte, E., Lefrancois, D., and Lombard, M. The rate of chromosome breakage is age dependent in lymphocytes of adult controls. Hum. Genet., 73: 290-297, 1986.
37. Tucker, J. D., Lee, D. A., Ramsey, M. J., Briner, J., Olsen, L., and Moore, D. H., II. On the frequency of chromosome exchanges in a control population measured by chromosome painting. Mutat. Res., 313: 193-202, 1994.
38. ISCN. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995.